covid
Allergologia et Immunopathologia Real life study of three years omalizumab in patients with difficult-to-control ...
Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Real life study of three years omalizumab in patients with difficult-to-control asthma
J. Jesús López Tiroa,
Corresponding author
, E. Angélica Contreras Contrerasa, M. Elena Ramírez del Pozoa, J. Gómez Veraa, D. Larenas Linnemannb
a Department of Allergy and Clinical Immunology, H.R. Lic. Adolfo López Mateos, ISSSTE, Mexico City, Mexico
b Allergy Staff, Hospital Medica Sur, Mexico City, Mexico
Read
4953
Times
was read the article
1274
Total PDF
3679
Total HTML
Share statistics
Article information
ISSN: 03010546
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 57 9 66
2025 11 261 69 330
2025 10 117 20 137
2025 9 119 25 144
2025 8 101 19 120
2025 7 118 24 142
2025 6 70 6 76
2025 5 126 5 131
2025 4 85 7 92
2025 3 84 9 93
2025 2 75 14 89
2025 1 79 8 87
2024 12 55 11 66
2024 11 35 2 37
2024 10 44 8 52
2024 9 55 7 62
2024 8 29 8 37
2024 7 41 4 45
2024 6 44 6 50
2024 5 49 6 55
2024 4 28 9 37
2024 3 72 4 76
2024 2 87 8 95
2024 1 52 10 62
2023 12 68 27 95
2023 11 72 26 98
2023 10 112 14 126
2023 9 71 6 77
2023 8 67 12 79
2023 7 81 9 90
2023 6 69 5 74
2023 5 111 8 119
2023 4 63 8 71
2023 3 39 5 44
2023 2 29 6 35
2023 1 20 5 25
2022 12 42 13 55
2022 11 19 10 29
2022 10 23 13 36
2022 9 20 19 39
2022 8 27 16 43
2022 7 27 9 36
2022 6 35 10 45
2022 5 38 11 49
2022 4 30 15 45
2022 3 16 9 25
2022 2 15 10 25
2022 1 23 9 32
2021 12 49 17 66
2021 11 17 20 37
2021 10 23 14 37
2021 9 17 9 26
2021 8 8 11 19
2021 7 8 15 23
2021 6 14 13 27
2021 5 14 21 35
2021 4 20 23 43
2021 3 14 14 28
2021 2 11 16 27
2021 1 15 11 26
2020 12 1 0 1
2020 11 0 4 4
2020 10 0 1 1
2020 9 0 1 1
2020 8 0 2 2
2020 7 0 1 1
2020 6 0 2 2
2020 5 0 2 2
2020 4 0 3 3
2020 3 0 6 6
2020 2 0 9 9
2020 1 0 12 12
2019 12 0 5 5
2019 10 0 3 3
2019 9 0 2 2
2019 8 0 12 12
2019 7 0 16 16
2019 6 0 25 25
2019 5 0 29 29
2019 4 0 21 21
2019 3 0 1 1
2019 2 0 6 6
2019 1 0 2 2
2018 12 0 6 6
2018 11 0 1 1
2018 10 0 7 7
2018 2 7 7 14
2018 1 7 5 12
2017 12 12 6 18
2017 11 12 11 23
2017 10 8 6 14
2017 9 16 10 26
2017 8 16 8 24
2017 7 12 11 23
2017 6 25 22 47
2017 5 27 13 40
2017 4 25 10 35
2017 3 23 30 53
2017 2 17 9 26
2017 1 17 5 22
2016 12 18 9 27
2016 11 23 12 35
2016 10 34 12 46
2016 9 19 10 29
2016 8 17 6 23
2016 7 18 10 28
2016 6 34 15 49
2016 5 17 16 33
2016 4 24 18 42
2016 3 22 18 40
2016 1 0 1 1
2015 11 1 0 1
2015 10 0 1 1
2015 6 0 3 3
2015 5 1 5 6
2015 4 13 38 51
2015 3 3 11 14
Show all

Follow this link to access the full text of the article